Dirk Schadendorf

Also affiliated with Essen University Hospital

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

25.0Author DataRank

Indexed papers

10in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 10 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics

Cell(2018)10.1016/j.cell.2018.02.052

Top 2%

8.1DataRank

Top 2%3980 citations

Katherine A. Hoadley, Laila M. Poisson, Alexander J. Lazar, Andrew D. Cherniack, Albert J. Kovatich +866 more

Papers

Driven by 37 papers — median percentile 97. Top paper: “Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial”.

Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial

The Lancet(2015)10.1016/s0140-6736(15)60898-4

N/A

13.9DataRank · unranked

1394 citations

Daniil Stroyakovskiy, Helen Gogas, Evgeny Levchenko, Filippo de Braud, James Larkin +29 more

An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics

Cell(2018)10.1016/j.cell.2018.02.052

Top 2%

8.1DataRank

Top 2%3980 citations

Katherine A. Hoadley, Laila M. Poisson, Alexander J. Lazar, Andrew D. Cherniack, Albert J. Kovatich +866 more

Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasion

Nature Genetics(2021)10.1038/s41588-021-00779-1

N/A

6.5DataRank · unranked

271 citations

Johannes C. Melms, Pratiksha I. Thakore, Kathryn Geiger-Schuller, Patricia Ho, Adrienne Luoma +17 more

Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics

Cell(2018)10.1016/j.cell.2018.03.033

Top 3%

6.4DataRank

Top 3%447 citations

Matthew H. Bailey, Hoifung Poon, Vesteinn Thorsson, Antonio Colaprico, Andreas Bender +883 more

Pan-cancer analysis of whole genomes

Nature(2020)10.1038/s41586-020-1969-6

Top 3%

5.9DataRank

Top 3%3307 citations

Lauri A. Aaltonen, Federico Abascal, Adam Abeshouse, Hiroyuki Aburatani, David J. Adams +1244 more

Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

Cell Reports(2018)10.1016/j.celrep.2018.03.046

N/A

5.5DataRank · unranked

186 citations

Francisco Sanchez-Vega, Konnor C. La, Joshua Armenia, Walid K. Chatila, Augustin Luna +869 more

Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib: a clinical validation study

The Lancet Oncology(2021)10.1016/s1470-2045(20)30726-9

N/A

4.9DataRank · unranked

94 citations

Jennifer Wiggins, Broderick C. Corless, Georgina V. Long, Keith T. Flaherty, Dirk Schadendorf +12 more

Analyses of non-coding somatic drivers in 2,658 cancer whole genomes

Nature(2020)10.1038/s41586-020-1965-x

Top 5%

4.6DataRank

Top 5%668 citations

Federico Abascal, Jeremiah A. Wala, Ofer Shapira, Grace Tiao, Henrik Hornshøj +1240 more

The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity

Cancer Cell(2023)10.1016/j.ccell.2023.05.014

N/A

1.8DataRank · unranked

96 citations

Johannes C. Melms, Meri Rogava, Chris J. Frangieh, Joanna Poźniak, Shivem B. Shah +28 more

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

New England Journal of Medicine(2015)10.1056/nejmoa1504030

N/A

1.3DataRank · unranked

8085 citations

Vanna Chiarion-Sileni, Rene Gonzalez, Jean Jacques Grob, C. Lance Cowey, Christopher D. Lao +35 more

Oncogenic Signaling Pathways in The Cancer Genome Atlas

Cell(2018)10.1016/j.cell.2018.03.035

N/A

1.2DataRank · unranked

3322 citations

Marco Mina, Joshua Armenia, Walid K. Chatila, Augustin Luna, Konnor C. La +891 more

Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma

New England Journal of Medicine(2014)10.1056/nejmoa1406037

N/A

1.1DataRank · unranked

1883 citations

Daniil Stroyakovskiy, Helen Gogas, Evgeny Levchenko, Filippo de Braud, James Larkin +30 more

Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma

Nature Medicine(2019)10.1038/s41591-019-0654-5

N/A

1.0DataRank · unranked

829 citations

Bastian Schilling, Derek Liu, Antje Sucker, Elisabeth Livingstone, Livnat Jerby-Arnon +34 more

Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility

Nature Genetics(2020)10.1038/s41588-020-0611-8

N/A

0.825DataRank · unranked

243 citations

D. Timothy Bishop, Stuart MacGregor, Mitchell J. Machiela, Alexander Stratigos, Paola Ghiorzo +95 more

MEK inhibition may increase survival of NRAS-mutated melanoma patients treated with checkpoint blockade: Results of a retrospective multicentre analysis of 364 patients

European Journal of Cancer(2018)10.1016/j.ejca.2018.04.010

N/A

0.635DataRank · unranked

68 citations

Selma Ugurel, Johanna Mangana, Markus Valentin Heppt, Thomas Kurt Eigentler, Carola Berking +5 more

Three-Year Overall Survival With Nivolumab Plus Relatlimab in Advanced Melanoma From RELATIVITY-047

Journal of Clinical Oncology(2025)10.1200/jco.24.01124

N/A

0.633DataRank · unranked

67 citations

F. Stephen Hodi, Evan J. Lipson, Dirk Schadendorf, Paolo A. Ascierto, Luis Matamala +14 more

Author Correction: Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma

Nature Medicine(2020)10.1038/s41591-020-0975-4

N/A

0.564DataRank · unranked

12 citations

Bastian Schilling, Derek Liu, Antje Sucker, Elisabeth Livingstone, Livnat Jerby-Arnon +34 more

Targeting the Atf7ip–Setdb1 Complex Augments Antitumor Immunity by Boosting Tumor Immunogenicity

Cancer Immunology Research(2021)10.1158/2326-6066.cir-21-0543

N/A

0.557DataRank · unranked

40 citations

Alireza Khodadadi‐Jamayran, Igor Dolgalev, Hyunwoo Cho, Sana Badri, Luis Chiriboga +28 more

Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2661

N/A

0.542DataRank · unranked

36 citations

Ashley V. Menk, Dayana B. Rivadeneira, Ryan C. Augustin, Mingchu Xu, Jun Li +47 more

Clinical validation of droplet digital PCR assays in detecting BRAFV600-mutant circulating tumour DNA as a prognostic biomarker in patients with resected stage III melanoma receiving adjuvant therapy (COMBI-AD): a biomarker analysis from a double-blind, randomised phase 3 trial

The Lancet Oncology(2025)10.1016/s1470-2045(25)00139-1

N/A

0.524DataRank · unranked

32 citations

Georgina V Long, James Garrett, Victoria Atkinson, Mario Santinami, Dirk Schadendorf +14 more

Loss of Pip4k2c confers liver-metastatic organotropism through insulin-dependent PI3K-AKT pathway activation

Nature Cancer(2024)10.1038/s43018-023-00704-x

N/A

0.464DataRank · unranked

21 citations

Tyler J. Aprati, Wei-Yu Chi, Johannes C. Melms, Clemens Hug, Stephanie H. Davis +40 more

Biomarker results from a phase II study of MEK1/2 inhibitor binimetinib (MEK162) in patients with advancedNRAS- orBRAF-mutated melanoma

Oncotarget(2019)10.18632/oncotarget.26753

N/A

0.457DataRank · unranked

20 citations

Sanjiv S. Agarwala, Axel Hauschild, Carola Berking, J. Thaddeus Beck, Dirk Schadendorf +12 more

Combination immunotherapy with anti-PD-L1 antibody and depletion of regulatory T cells during acute viral infections results in improved virus control but lethal immunopathology

PLoS Pathogens(2020)10.1371/journal.ppat.1008340

N/A

0.406DataRank · unranked

14 citations

Malgorzata Drabczyk-Pluta, Eva Pastille, Torben Knuschke, Tanja Werner, Nadine Honke +22 more

Multi-modal pooled Perturb-CITE-Seq screens in patient models define novel mechanisms of cancer immune evasion

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.01.267211

N/A

0.375DataRank · unranked

5 citations

Johannes C. Melms, Pratiksha I. Thakore, Kathryn R. Geiger-Schuller, Patricia Ho, Adrienne Luoma +15 more

Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of SAR439459, a TGFβ inhibitor, as monotherapy and in combination with cemiplimab in patients with advanced solid tumors: Findings from a phase 1/1b study

Clinical and Translational Science(2024)10.1111/cts.13854

N/A

0.360DataRank · unranked

10 citations

Debbie Robbrecht, Ryan Sullivan, Bernard Doger, Armando Santoro, Minal Barve +16 more

The CD58:CD2 axis is co-regulated with PD-L1 via CMTM6 and governs anti-tumor immunity

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.21.485049

N/A

0.360DataRank · unranked

10 citations

Johannes C. Melms, Meri Rogava, Chris J. Frangieh, Shivem B. Shah, Zachary Walsh +21 more

Single-cell RNA-sequencing and -imaging of melanoma ecosystems reveals sources of resistance to immune checkpoint blockade.

Journal of Clinical Oncology(2018)10.1200/jco.2018.36.15_suppl.3074

N/A

0.208DataRank · unranked

1 citations

Livnat Jerby-Arnon, Asaf Rotem, Parin Shah, David Liu, Gao Zhang +13 more

Author Correction: Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis

Communications Biology(2022)10.1038/s42003-022-03769-z

N/A

0.165DataRank · unranked

2 citations

Lars Feuerbach, Chen Hong, David Mas-Ponte, Randi Istrup Pedersen, PCAWG Drivers and Functional Interpretation Group +1255 more

Retrotransposons are co-opted to activate hematopoietic stem cells and erythropoiesis

Science(2024)10.1126/science.ado6836

N/A

0DataRank · unranked

25 citations

Brandon Chen, Zhiyu Zhao, Gabriele Allies, Antonella Iannaccone, Animesh Paul +10 more

Selenoprotein O Promotes Melanoma Metastasis and Regulates Mitochondrial Complex II Activity

Cancer Research(2024)10.1158/0008-5472.can-23-2194

N/A

0DataRank · unranked

18 citations

Marie Sabatier, Vijayashree Ramesh, Krystina J. Szylo, Cameron Fraser, Alex Pon +13 more

Editorial: Targeting Indoleamine 2,3-dioxygenases and Tryptophan Dioxygenase for Cancer Immunotherapy

Frontiers in Immunology(2021)10.3389/fimmu.2021.789473

N/A

0DataRank · unranked

4 citations

Vibeke Krüse, Dirk Schadendorf, Alexander J. Muller, George C. Prendergast, Liève Brochez

Molecular pathology as a diagnostic aid in difficult-to-classify melanocytic tumours with spitzoid morphology

European Journal of Cancer(2021)10.1016/j.ejca.2021.02.025

N/A

0DataRank · unranked

9 citations

Georg Lodde, Rajmohan Murali, Manuel Philip, Ioana Cosgarea, Philipp Jansen +16 more

Data from Nuclear Receptor Coactivator NCOA3 Regulates UV Radiation–Induced DNA Damage and Melanoma Susceptibility

(2023)10.1158/0008-5472.c.6513430.v1

N/A

0DataRank · unranked

0 citations

Vladimir Bezrookove, Mehdi Nosrati, Altaf A. Dar, James R. Miller, Stanley P. L. Leong +10 more

Skin cancer classification via convolutional neural networks: systematic review of studies involving human experts

European Journal of Cancer(2021)10.1016/j.ejca.2021.06.049

N/A

0DataRank · unranked

255 citations

Roman C. Maron, Achim Hekler, Jochen Utikal, Catarina Barata, Raymond L. Barnhill +60 more

PI3K/mTORC2-RICTOR axis in early squamous non-small-cell lung cancer: genomics, molecular expression, and clinical relevance

Therapeutic Advances in Medical Oncology(2025)10.1177/17588359251370510

N/A

0DataRank · unranked

0 citations

Lorenzo Belluomini, Federico Monaca, Michele Simbolo, Antonio Agostini, Andrea Mafficini +18 more

Author Correction: Combined burden and functional impact tests for cancer driver discovery using DriverPower

Nature Communications(2022)10.1038/s41467-022-32343-8

N/A

0DataRank · unranked

0 citations

PCAWG Drivers and Functional Interpretation Working Group, Federico Abascal, Samirkumar B. Amin, Pratiti Bandopadhayay, Rameen Beroukhim +1242 more

Nuclear Receptor Coactivator NCOA3 Regulates UV Radiation–Induced DNA Damage and Melanoma Susceptibility

Cancer Research(2021)10.1158/0008-5472.can-20-3450

N/A

0DataRank · unranked

19 citations

Vladimir Bezrookove, Mehdi Nosrati, Altaf A. Dar, James R. Miller, Stanley P. L. Leong +10 more

Dirk Schadendorf

Indexed papers

Top data-sharing exemplar

Papers